Bay­er tar­gets COPD in a new dis­cov­ery al­liance with Hap­lo­gen, Evotec

Bay­er is adding COPD to its list of dis­cov­ery tar­gets.

The Ger­man phar­ma com­pa­ny has tied the knot with a col­lab­o­ra­tive ef­fort …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.